Implications of altered iron homeostasis for age-related macular degeneration

Frontiers in Bioscience

Volumn 16, Issue 4, 2011, Pages 1551-1559

  Blasiak, Janusz ^a   Szaflik, Jerzy ^b   Szaflik, Jacek Pawel ^b  

^a UNIVERSITY OF LODZ   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Age related macular degeneration; AMD; Iron; Iron homeostasis; Oxidative stress; Review

Indexed keywords

MUS;

IRON;

AGED; HOMEOSTASIS; HUMAN; IRON OVERLOAD; METABOLISM; PATHOLOGY; RETINA; RETINA MACULA DEGENERATION; REVIEW;

AGED; HOMEOSTASIS; HUMANS; IRON; IRON OVERLOAD; MACULAR DEGENERATION; RETINA;

EID: 79955038329     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3804     Document Type: Article

References (87)

1. G. Perry, L. M. Sayre, C. S. Atwood, R. J. Castellani, A. D. Cash, C. A. Rottkamp, M. A. Smith: The role of iron and copper in the aetiology of neurodegenerative disorders: therapeutic implications. CNS Drugs 16, 339-352 (2002) (Pubitemid 34548201)
2. P. Hahn, A. H. Milam, J. F. Dunaief: Maculas affected by age related macular degeneration contain increased chelatable iron in the retinal pigment epithelium and Bruch's membrane. Arch Ophthalmol 121, 1099-1105 (2003) (Pubitemid 36962162)
3. J. L. Dunaief, C. Richa, E. P. Franks, R. L. Schultze, T. S. Aleman, J. F. Schenck, E. A. Zimmerman, D. G. Brooks: Macular degeneration in a patient with aceruloplasminemia, a disease associated with retinal iron overload. Ophthalmology 112, 1062-1065 (2005) (Pubitemid 40797462)
4. H. Shichi: Microsomal electron transfer system of bovine retinal pigment epithelium. Exp Eye Res 8, 60-68 (1969)
5. O. O. Pedersen: An electron microscopic study of the permeability of intraocular blood vessels using lanthanum as a tracer in vivo. Exp Eye Res 29, 61-69 (1979) (Pubitemid 10222724)
6. G. Moiseyev, Y. Takahashi, Y. Chen Y, S. Gentleman, T. M. Redmond, R. K. Crouch, J. X. Ma JX: RPE65 is an iron(II)-dependent isomerohydrolase in the retinoid visual cycle. J Biol Chem 281, 2835-2840 (2006) (Pubitemid 43845748)
7. N. C. Andrews: Disorders of iron metabolism. N Engl J Med 341, 1986-1995 (1999) (Pubitemid 30010408)
8. A. T. McKie, G. O. Latunde-Dada, S. Miret, J. A. McGregor, G. J. Anderson, C. D. Vulpe, J. M. Wrigglesworth, R. J. Simpson: Molecular evidence for the role of a ferric reductase in iron transport. Biochem Soc Trans 30, 722-724 (2002) (Pubitemid 35001638)
9. A. M. Koorts, M. Viljoen: Ferritin and ferritin isoforms I: structure-function relationships, synthesis, degradation and secretion. Arch Physiol Biochem 113, 30-54 (2007) (Pubitemid 46825687)
10. A. C. Chua, R. M. Graham, D. Trinder, J. K. Olynyk: The regulation of cellular iron metabolism. Crit Rev Clin Lab Sci 44, 413-459 (2007) (Pubitemid 47619398)
11. P. Aisen: Transferrin receptor 1. Int J Biochem Cell Biol 36, 2137-2143 (2004) (Pubitemid 39094437)
12. J. A. Watkins, J. D. Altazan, P. Elder, C. Y. Li, M. T. Nunez, X. X. Cui, J. Glass: Kinetic characterization of reductant dependent processes in iron mobilization from endocytic vesicles. Biochemistry 31, 5820-5830 (1992)
13. P. K. Bali, O. Zak, P. Aisen: A new role for the transferrin receptor in the release of iron from transferrin. Biochemistry 30: 324-328 (1991)
14. R. S. Ohgami, D. R. Campagna, E. L. Greer, B. Antiochos, A. McDonald, J. Chen, J. J. Sharp, Y. Fujiwara, J. E. Barker, M. D. Fleming: Identification of a ferrireductase required for efficient transferrin-dependent iron uptake in erythroid cells. Nat Genet 37, 1264-1269 (2005) (Pubitemid 41568711)
15. G. J. Anderson, C. D. Vulpe: Mammalian iron transport. Cell Mol Life Sci 66, 3241-3261 (2009)
16. H. Gunshin, B. Mackenzie, U. V. Berger, Y. Gunshin, M. F. Romero, W. F. Boron, S. Nussberger, J. L. Gollan, M. A. Hediger: Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 388, 482-488, (1997) (Pubitemid 27328927)
17. N. C. Andrews, P. J. Schmidt: Iron homeostasis. Annu Rev Physiol 69, 69-85 (2007) (Pubitemid 46457636)
18. C. Pigeon, G. Ilyin, B. Courselaud, P. Leroyer, B. Turlin, P. Brissot, O. Loreal: A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 276, 7811-7819 (2001)
19. J. F. Collins, M. Wessling-Resnick, M. D. Knutson: Hepcidin regulation of iron transport. J Nutr 138, 2284-2288 (2008)
20. I. De Domenico, D. M. Ward, C. Langelier, M. B. Vaughn, E. Nemeth, W. I. Sundquist, T. Ganz, G. Musci, J. Kaplan: The molecular mechanism of hepcidin-mediated ferroportin downregulation. Mol Biol Cell 18, 2569-2578 (2007) (Pubitemid 47025722)
21. J. L. Babitt, F. W. Huang, D. M. Wrighting, Y. Xia, Y. Sidis, T. A. Samad, J. A. Campagna, R. T. Chung, A. L. Schneyer, C. J. Woolf, N. C. Andrews, H. Y. Lin: Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet 38, 531-539 (2006)
22. G. J. Anderson, D. M. Frazer: Iron metabolism meets signal transduction. Nat Genet 38, 503-504 (2006)
23. I. Napier, P. Ponka, D. R. Richardson: Iron trafficking in the mitochondrion: novel pathways revealed by disease. Blood 105, 1867-1874 (2005) (Pubitemid 40731766)
24. A. D. Sheftel, A. S. Zhang, C. Brown, O. S. Shirihai, P. Ponka P: Direct interorganellar transfer of iron from endosome to mitochondrion. Blood 110, 125-132 (2007) (Pubitemid 47026827)
25. G. C. Shaw, J. J. Cope, L. Li, K. Corson, C. Hersey, G. E. Ackermann, B. Gwynn, A. J. Lambert, R. A. Wingert, D. Traver, N. S. Trede, B. A. Barut, Y. Zhou, E. Minet E, A. Donovan, A. Brownlie, R. Balzan, M. J. Weiss, L. L. Peters, J. Kaplan, L. I. Zon, B. H. Paw: Mitoferrin is essential for erythroid iron assimilation. Nature 440, 96-100 (2006) (Pubitemid 43336274)
26. B. Halliwell, J. M. Gutteridge: Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol 186, 1-85 (1990) (Pubitemid 20279941)
27. Z. Radak, I. Boldogh: 8-oxo-7,8-dihydroguanine: Link to gene expression, aging and defense against oxidative stress. Free Radic Biol Med 49, 587-596 (2010)
28. Y. Kohgo, K. Ikuta, T. Ohtake, Y. Torimoto, J. Kato: Body iron metabolism and pathophysiology of iron overload. Int J Hematol 88, 7-15 (2008)
29. T. A. Dragani: Risk of HCC: genetic heterogeneity and complex genetics. J Hepatol 52, 252-257 (2010)
30. T. M. Redmond, E. Poliakov, S. Yu, J. Y. Tsai, Z. Lu, S. Gentleman: Mutation of key residues of RPE65 abolishes its enzymatic role as isomerohydrolase in the visual cycle. Proc Natl Acad Sci USA 102, 13658-13663 ( 2005) (Pubitemid 41420904)
31. J. L. Dunaief: Iron induced oxidative damage as a potential factor in age-related macular degeneration: the Cogan Lecture. Invest Ophthalmol Vis Sci 47, 4660-4664 (2006) (Pubitemid 46586359)
32. A. Loh, M. Hadziahmetovic, J. L. Dunaief: Iron homeostasis and eye disease. Biochim Biophys Acta 1790, 637-649 (2009)
33. M. Doly, B. Bonhomme, J. C. Vennat: Experimental study of the retinal toxicity of hemoglobinic iron. Ophthalmic Res 18, 21-27 (1986) (Pubitemid 16170338)
34. O. Vergara, T. Ogden, S. Ryan: Posterior penetrating injury in the rabbit eye: effect of blood and ferrous ions. Exp Eye Res 49, 1115-1126 (1989) (Pubitemid 20043718)
35. A. Tawara: Transformation and cytotoxicity of iron in siderosis bulbi. Invest Ophthalmol Vis Sci 27, 226-236 (1986) (Pubitemid 16129789)
36. M. G. Yefimova, J. C. Jeanny, N. Keller, C. Sergeant, X. Guillonneau, C. Beaumont, Y. Courtois: Impaired retinal iron homeostasis associated with defective phagocytosis in Royal College of Surgeons rats. Invest Ophthalmol Vis Sci 43, 537-545 (2002) (Pubitemid 34113240)
37. A. Salminen, K. Kaarniranta: Regulation of the aging process by autophagy. Trends Mol Med 15, 217-224 (2009)
38. K. Kaarniranta: Autophagy - hot topic in AMD. Acta Ophthalmol 88, 387-388 (2010)
39. K. Yamaguchi, S. Takahashi, T. Kawanami, T. Kato, H. Sasaki: Retinal degeneration in hereditary ceruloplasmin deficiency. Ophthalmologica 212, 11-14 (1998) (Pubitemid 28005099)
40. F. W. Newell, R. O. Johnson, P. R. Huttenlocher: Pigmentary degeneration of the retina in the Hallervorden-Spatz syndrome. Am J Ophthalmol 88, 467-471 (1979) (Pubitemid 9245065)
41. J. L. Dunaief, C. Richa, E. P. Franks, R. L. Schultze, T. S. Aleman, J. F. Schenck, E. A. Zimmerman, D. G. Brooks: Macular degeneration in a patient with aceruloplasminemia, a disease associated with retinal iron overload. Ophthalmology 112, 1062-1065 (2005) (Pubitemid 40797462)
42. P. Hahn, Y. Qian, T. Dentchev, L. Chen, J. Beard, Z. L. Harris, J. L. Dunaief: Disruption of ceruloplasmin and hephaestin in mice causes retinal iron overload and retinal degeneration with features of age-related macular degeneration. Proc Natl Acad Sci USA 101, 13850-13855 (2004) (Pubitemid 39298496)
43. T. Dentchev, P. Hahn, J. L. Dunaief: Strong labeling for iron and the iron-handling proteins ferritin and ferroportin in the photoreceptor layer in age-related macular degeneration. Arch Ophthalmol 123, 1745-1746 (2005) (Pubitemid 41785113)
44. C. Kaur, W. S. Foulds, E. A. Ling: Blood-retinal barrier in hypoxic ischaemic conditions: basic concepts, clinical features and management. Prog Retin Eye Res 27, 622-647 (2008)
45. R. D. Jager, W. F. Mieler, J. W. Miller: Age-related macular degeneration. N Eng J Med 358, 2606-2617 (2008)
46. S. Amasheh, S. Milatz, S. M. Krug, A. G. Markov, D. Günzel, M. Amasheh, M. Fromm: Tight junction proteins as channel formers and barrier builders. Ann N Y Acad Sci 1165, 211-219 (2009)
47. J. R. Burdo, D. A. Antonetti, E. B. Wolpert, J. R. Connor: Mechanisms And regulation of transferring and iron transport in a model blood-brain barrier system. Neuroscience 121, 883-890 (2003) (Pubitemid 37324587)
48. R. C. Hunt, A. A. Davis: Release of iron by human retinal pigment epithelial cells. J Cell Physiol 152,102-110 (1992)
49. M. G. Yefimova, J. C. Jeanny, X. Guillonneau, N. Keller, J. Nguyen-Legros, C. Sergeant, F. Guillou, Y. Courtois: Iron, ferritin, transferrin, and transferrin receptorin the adult rat retina. Invest Ophthalmol Vis Sci 41, 2343-2351 (2000) (Pubitemid 30451012)
50. R. C. Hunt, A. Dewey, A. A. Davis: Transferrin receptors on the surfaces of retinal pigment epithelial cells are associated with the cytoskeleton. J Cell Sci 92, 655-666 (1989)
51. X. He, P. Hahn, J. Lacovelli, R. Wong, C. King, R. Bhistikul, M. Massaro-Giordano, J. L. Dunaief: Iron homeostasis and toxicity in retinal degeneration. Ptog Retin Eye Res 26, 649-673 (2007) (Pubitemid 47615564)
52. J. H. Cheah, S. F. Kim, L. D. Hester, K. W. Clancy, S. E. Patterson, V. Papadopoulos, S. H. Snyder: NMDA receptor-nitric oxide transmission mediates neuronal iron homeostasis via the GTPase Dexras1. Neuron 51, 431-440 (2006) (Pubitemid 44209322)
53. L. Chen, T. Dentchev, R. Wong, P. Hahn, R. Wen, J. Bennett, J. L. Dunaief: Increased expression of ceruloplasmin in the retina following photic injury. Mol Vis 9, 151-158 (2003) (Pubitemid 38097580)
54. J. P. Gnana-Prakasam, P. M. Martin, S. B. Smith, V. Ganapathy: Expression and function of iron-regulatory proteins in retina. IUBMB Life 62, 363-370
55. R. Klein, Q. Wang, B. E. Klein, E. E. Moss, S. M. Meuer: The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity. Invest Ophthalmol Vis Sci 36, 182-191 (1995)
56. H. M. Leibowitz, D. E. Krueger, L. R. Maunder, R. C. Milton, M. M. Kini, H. A. Kahn, R. J. Nickerson, J. Pool, T. L. Colton, J. P. Ganley, J. I. Loewenstein, T. R. Dawber: The Framingham Eye Study monograph: An ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975. Surv Ophthalmol 24, 335-610 (1980)
57. X. Ding, M. Patel, C.C. Chan: Molecular pathology of gerelated macular degeneration. Prog Retinal Eye Res 28, 1-18 (2009)
58. G. A. Garinis, G. T. van der Horst, J. Vijg, J. H. Hoeijmakers: DNA damage and ageing: new-age ideas for an age-old problem. Nature Cell Biol 10, 1241-1247 (2008)
59. AREDS. A randomized, placebo-controlled clinical trial of high-dose supplementation with vitamins c and e, beta carotene, and zinc for age-related macular degeneration and vision loss. Arch Ophthalmol 119, 1417-1436 (2001)
60. J. K. Kiecolt-Glaser: Stress, food, and inflammation: psychoneuroimmunology and nutrition at the cutting edge. Psychosom Med 72, 365-369 (2010)
61. I. Chowers, R. Wong, T. Dentchev, R. H. Farkas, J. Iacovelli, T. L. Gunatilaka, N. E. Medeiros, J. B. Presley, P. A. Campochiaro, C. A. Curcio, J. F. Dunaief, D. J. Zack DJ: The iron carrier transferrin is upregulated in retinas from patients with agerelated macular degeneration. Invest Ophthalmol Vis Sci 47, 2135-2140 (2006) (Pubitemid 46768298)
62. T. Ganz: Hepcidin and its role in regulating systemic iron metabolism. Hematology Am Soc Hematol Educ Program 29-35, (2006)
63. G. S. Hageman, D. H. Anderson, L. V. Johnson, L. S. Hancox, A. J. Taiber, L. I. Hardisty, J. L. Hageman, H. A. Stockman, J. D. Borchardt, K. M. Gehrs, R. J. Smith, G. Silvestri, S. R. Russell, C. C. Klaver, I. Barbazetto, S. Chang, L. A. Yannuzzi, G. R. Barile, J. C. Merriam, R. T. Smith, A. K. Olsh, J. Bergeron, J. Zernant, J. E. Merriam, B. Gold, M. Dean, R. Allikmets: A common haplotype in the complement regulatory gene factor H (HF1/ CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA 102, 7227-7232 (2005) (Pubitemid 40696361)
64. R. J. Klein, C. Zeiss, E. Y. Chew, J. Y. Tsai, R. S. Sackler, C. Haynes, A. K. Henning, J. P. SanGiovanni, S. M. Mane, S. T. Mayne, M. B. Bracken, F. L. Ferris, J. Ott, C. Barnstable, J. Hoh: Complement factor H polymorphism in age-related macular degeneration. Science 308, 385-389 (2005) (Pubitemid 40530070)
65. A. O. Edwards, R. Ritter, K. J. Abel, A. Manning, C. Panhuysen, L. A. Farrer: Complement factor H polymorphism and agerelated macular degeneration. Science 308, 421-424 (2005) (Pubitemid 40530082)
66. J. L. Haines, M. A. Hauser, S. Schmidt, W. K. Scott, L. M. Olson, P. Gallins, K. L. Spencer, S. Y. Kwan, M. Noureddine, J. R. Gilbert, N. Schnetz-Boutaud, A. Agarwal, E. A. Postel, M. A. Pericak-Vance: Complement factor H variant increases the risk of age-related macular degeneration. Science 308, 419-421 (2005) (Pubitemid 40530081)
67. B. Gold, J. E. Merriam, J. Zernant, L. S. Hancox, A. J. Taiber, K. Gehrs, K. Cramer, J. Neel, J. Bergeron, G. R. Barile, R. T. Smith: Variation in factor B(BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet 38, 458-462, (2006)
68. W. Vogi, R. Nolte, D. Brunahl: Binding of iron to the 5th component of human complement directs oxygen radicalmediated conversion to specific sites and causes nonenzymic activation. Complement Inflamm 8, 313-319 (1991)
69. D. W. Lee, J. K. Andersen, D. Kaur: Iron dysregulation and neurodegeneration: the molecular connection. Mol Interv 6, 89-97 (2006)
70. L. R. Zacharski, G. S. Gerhard: Atherosclerosis: a manifestation of chronic iron toxicity? Vasc Med 8, 153-155 (2003) (Pubitemid 38220192)
71. P. Hahn, G. S. Ying, J. Beard, J. L. Dunaief: Iron levels in human retina: sex difference and increase with age. Neurorepor 17, 1803-1806 (2006) (Pubitemid 44948111)
72. P. Hahn, Y. Song, G.S. Ying, X. He, J. Beard, J. L. Dunaief: Age-dependent and gender-specific changes in mouse tissue iron by strain. Exp Gerontol 44, 594-600 (2009)
73. T. Sliwinski, J. Blasiak, A. K. Kurowska, J. P. Szaflik: Role of the 25129A>C polymorphism of the NRF2 gene in AMD patients in a Polish subpopulation. Okulistyka 1, 59-62 (2010)
74. R. W. Wong, D. C. Richa, P. Hahn, W. R. Green, J. L. Dunaief: Iron toxicity as a potential factor in AMD. Retina 27, 997-1003 (2007) (Pubitemid 350303998)
75. J. B. Porter: Optimizing iron chelation strategies in beta-thalassaemia major. Blood Rev 23, S3-S7 (2009)
76. Klaassen CD. Heavy metals and heavy-metal antagonists. In: Hardman JG, Gilman AG, Limbird LE, editors-in-chief. Goodman and Gilman's the Pharmacological Basis of Therapeutics, 9th ed. New York: McGraw-Hill 148-156 (1996)
77. .A. Klettner, S. Koinzer, V. Waetzig, T. Herdegen, J. Roider: Deferoxamine mesylate is toxic for retinal pigment epithelium cells in vitro, and its toxicity is mediated by p38. Cutan Ocul Toxicol 29, 122-129 (2010)
78. J. S. Baath, W. C. Lam, M. Kirby, A. Chun: Deferoxamine-related ocular toxicity: incidence and outcome in a pediatric population. Retina 28, 894-899 (2008)
79. Haimovici R, D'Amico DJ, Gragoudas ES, Sokol S: The expanded clinical spectrum of deferoxamine retinopathy. Ophthalmology 109, 164-171 (2002) (Pubitemid 34027442)
80. N. Lukinova, J. Iacovelli, T. Dentchev, N. Wolkow, A. Hunter, D. Amado, G. S. Ying, J. R. Sparrow, J. L. Dunaief: Iron chelation protects the retinal pigment epithelial cell line ARPE-19 against cell death triggered by diverse stimuli. Invest Ophthalmol Vis Sci 50, 1440-1447 (2009)
81. T. Ganz: Hepcidin and its role in regulating systemic iron metabolism. Hematology Am Soc Hematol Educ Program 29-35, (2006)
82. G. Liu, P. Men, G. Perry, M. A. Smith: Nanoparticle and iron chelators as a potential novel Alzheimer therapy. Methods Mol Biol 610, 123-144 (2010)
83. B. Ghosh, T. Antonio, M. E. Reith, A. K. Dutta: Discovery of 4-(4-(2-((5-Hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)(propyl)amino)ethyl) piperazin-1-yl)quinolin-8-ol and its analogues as highly potent dopamine D2/D3 agonists and as iron chelator: in vivo activity indicates potential application in symptomatic and neuroprotective therapy for Parkinson's disease. J Med Chem 53, 2114-2125 (2010)
84. M. Whitnall, D. R. Richardson: Iron: a new target for pharmacological intervention in neurodegenerative diseases. Semin Pediatr Neurol 13, 186-197 (2006) (Pubitemid 44709656)
85. A. Araujo, G. Drelichman, R. D. Cancado, N. Watman, S. M. Magalhaes, M. Duhalde, J. Marfil, A. Feliu, L. Clementina, A. Linares Ballesteros, M. Di Stefano: Management of transfusional iron overload in Latin America: current outlook and expert panel recommendations. Latin American Experts Panel. Hematology 14, 22-32 (2009)
86. A. Lotery, D. Trump: Progress in defining the molecular biology of age related macular degeneration. Hum Genet 122, 219-236 (2007) (Pubitemid 47616531)
87. W. H. Waugh: Iron chelation by dibasic amino acid prevents glycoprotein insolubilities: a strategy to inhibit age-related macular degeneration? J Appl Res 4, 208-214 (2004) (Pubitemid 39387295)